Received: 6 November 2020
Accepted: 11 May 2021
First Online: 26 June 2021
: This study was approved by the University of North Carolina at Chapel Hill Institutional Review Board based on a rely on the Kaiser Permanente Northwest IRB. The Kaiser Permanente Northwest IRB granted the ASCEND study a waiver of informed consent for all data collection activities. ASCEND is a pragmatic trial and obtaining signed consent would unnaturally restrict our study sample, diminishing the external validity of our findings. The project is promoting standard clinical care and quality improvement in the CHC setting.
: Not applicable.All methods were performed in accordance with the relevant guidelines and regulations (Declaration of Helsinki).
: The authors declare that they have no competing interests.